GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd.verified

1796.TWO

Price:

$46.8

Market Cap:

$1.94B

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes mushrooms, lactic acid bacteria, bacteria, yeast, and algae; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; packaging equipment; microbial fermentation toll manufactu...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-07-26

Stock Exchange

TWO

Ticker

1796.TWO

The ROE as of December 2025 (TTM) for GeneFerm Biotechnology Co., Ltd. (1796.TWO) is -0.10%

According to GeneFerm Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -0.10%. This represents a change of 253.33% compared to the average of -0.03% of the last 4 quarters.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Historical ROE (quarterly & annually)

How has 1796.TWO ROE performed in the past?

The mean historical ROE of GeneFerm Biotechnology Co., Ltd. over the last ten years is 4.02%. The current -0.10% ROE has changed -102.58% with respect to the historical average. Over the past ten years (40 quarters), 1796.TWO's ROE was at its highest in in the June 2023 quarter at 5.54%. The ROE was at its lowest in in the September 2024 quarter at -1.43%.

Quarterly (TTM)
Annual

Average

4.02%

Median

4.41%

Minimum

-7.07%

Maximum

13.96%

GeneFerm Biotechnology Co., Ltd. (1796.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of GeneFerm Biotechnology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 571.76%

Maximum Annual ROE = 13.96%

Minimum Annual Increase = -120.48%

Minimum Annual ROE = -7.07%

Quarterly (TTM)
Annual
YearROEChange
2024-2.86%-120.48%
202313.96%24.08%
202211.25%46.49%
20217.68%571.76%
20201.14%-116.17%

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Average ROE

How has 1796.TWO ROE performed in the past?

The current ROE of GeneFerm Biotechnology Co., Ltd. (1796.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.45%

5-year avg

6.23%

10-year avg

4.02%

GeneFerm Biotechnology Co., Ltd. (1796.TWO) ROE vs. Peers

How is 1796.TWO’s ROE compared to its peers?

GeneFerm Biotechnology Co., Ltd.’s ROE is greater than LIWANLI Innovation Co., Ltd. (-3.46%), less than Winston Medical Supply Co., Ltd. (32.89%), less than TSH Biopharm Corporation Limited (8.29%), greater than InnoPharmax Inc. (-18.51%), greater than Golden Biotechnology Corporation (-126.92%), greater than Allied Biotech Corporation (-4.90%), less than Crystalvue Medical Corporation (14.85%), greater than Sunny Pharmtech Inc. (-27.76%), less than BenQ Medical Technology Corporation (7.82%), greater than OK Biotech Co., Ltd. (-1.66%),

Build a custom stock screener for GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneFerm Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneFerm Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is GeneFerm Biotechnology Co., Ltd.'s ROE?

How is the ROE calculated for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?

What is the highest ROE for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?

What is the 3-year average ROE for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?

What is the 5-year average ROE for GeneFerm Biotechnology Co., Ltd. (1796.TWO)?

How does the current ROE for GeneFerm Biotechnology Co., Ltd. (1796.TWO) compare to its historical average?